
Login
Who's Online
We have 202 guests and no members online
Statistics
- Users 5540
- Articles 744
- Articles View Hits 17430985
Why Use This Site for Advertisement?
Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy. |
|
Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology. The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation. |
Advertisement Opportunities
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
1 | Full banner | Located in rotation with other banners on all pages, including the home page |
2 | Home page banner or text links | Located only on the home page. Always visible in 1st or 2nd news item in center of the home page |
3 | Cube banner | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
4 | Text links | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- Kiwi Gene therapy scientist's warning over GMO bill - RNZ
Mon, 17 Mar 2025 23:05:2 GMT - Sarepta Therapeutics' Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Shows Safety in 5-Year Data - CGTLive™
Mon, 17 Mar 2025 21:39:4 GMT - Buy Rating for Benitec Biopharma Driven by Promising Gene Therapy Developments and Positive Clinical Outcomes - TipRanks
Mon, 17 Mar 2025 21:04:0 GMT - Patient Cured of Sickle Cell Anemia With Innovative Gene Therapy - Pharmacy Times
Mon, 17 Mar 2025 18:35:4 GMT - DoD grant funds Hollings researcher's idea to pursue gene therapy for cancer - Medical University of South Carolina
Mon, 17 Mar 2025 18:34:4 GMT - 3rd Gene Therapy Potency Assay Summit 2025 - pharmaphorum
Mon, 17 Mar 2025 17:55:1 GMT - Gene Therapy Offers Breakthrough Cure for Sickle Cell in U.S. - TV360
Mon, 17 Mar 2025 17:40:0 GMT - New Gene Therapy Cures Man's Sickle Cell Anemia - ExtremeTech
Mon, 17 Mar 2025 17:30:0 GMT - New Gene Therapy Cures Man's Sickle Cell Anemia - Yahoo
Mon, 17 Mar 2025 17:30:0 GMT - India’s blood cancer gene therapy shows 73% response rate in clinical trials: Report - Hindustan Times
Mon, 17 Mar 2025 12:38:4 GMT - Gene Therapy Market Projected to Reach USD 27,250.20 Million by 2034, Growing at a CAGR of 27.1% - WhaTech
Mon, 17 Mar 2025 11:54:3 GMT - Gene therapy delivers alternative sickle cell cure in US - Punch Newspapers
Mon, 17 Mar 2025 11:27:3 GMT - Gene Therapy Achieves Complete Cure for Sickle Cell Anemia in New York Patient - geneonline
Mon, 17 Mar 2025 10:01:0 GMT - [Latest] The Future of Cell & Gene Therapy Manufacturing Services Market: Forecasting the Next Decade - openPR
Mon, 17 Mar 2025 01:31:0 GMT - SpliceBio Doses First Patient in Trial for Stargardt Gene Therapy SB-007 - CGTLive™
Sun, 16 Mar 2025 08:00:0 GMT